Pure Global: Vietnam's Regulatory Shift & The MedTech Domino Effect in ASEAN Podcast By  cover art

Pure Global: Vietnam's Regulatory Shift & The MedTech Domino Effect in ASEAN

Pure Global: Vietnam's Regulatory Shift & The MedTech Domino Effect in ASEAN

Listen for free

View show details
This week, we dive into the landmark announcement from Vietnam's Ministry of Health: the full and immediate implementation of the ASEAN Medical Device Directive (AMDD). This decision is a game-changer for the region, effectively dismantling long-standing regulatory barriers and paving the way for a more unified market. We explore how this shift impacts time-to-market, costs, and overall strategy for MedTech companies. Consider a Malaysian cardiac device firm that just saw its 18-month Vietnam entry plan shrink to just six months. This isn't just a procedural update; it's the unlocking of significant commercial potential across Southeast Asia. What You'll Learn: - What exactly is the ASEAN Medical Device Directive and why does Vietnam's full adoption matter now? - How does this change the 'single-market' strategy for companies entering Southeast Asia? - What specific document, the CSDT, is now the key to unlocking multiple ASEAN markets? - Which countries are now under pressure to follow Vietnam's lead? - How does regulatory harmonization impact investor confidence and venture capital inflow? - What are the immediate opportunities for MedTech startups versus established multinational companies? - How can you leverage your existing approvals in one ASEAN country to accelerate entry into others? Navigating the complexities of global market access is challenging, but you don't have to do it alone. Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, leveraging local expertise and advanced AI to streamline your expansion. Whether it's developing a multi-market strategy or compiling a technical dossier, we can help. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn more.
No reviews yet